THE CONCENTRATION OF HSP70 IN THE CYTOSOL AND MITOCHONDRIA OF THE BRAIN IN ANIMALS WITH EXPERIMENTAL AUTOIMMUNE ENCEPHALO- MYELITIS AND AFTER THE TIME COURSE OF INTRANASALLY ADMINISTERED N-PHENYLACETYL-L-PROLYLGLYCINE ETHYL ESTER (NOOPEPT)


  • B.S. Burlaka Zaporizhzhia State Medical University, Ukraine
  • I.F. Belenichev Zaporizhzhia State Medical University, Ukraine
  • I.B. Samura Zaporizhzhia State Medical University, Ukraine
  • N.V. Bukhtiyarova Zaporizhzhia State Medical University, Ukraine
Keywords: HSP 70, experimental autoimmune encephalomyelitis, N-phenylacetyl-L-prolylglycine ethyl ester

Abstract

THE CONCENTRATION OF HSP70 IN THE CYTOSOL AND MITOCHONDRIA OF THE BRAIN IN ANIMALS WITH EXPERIMENTAL AUTOIMMUNE ENCEPHALO- MYELITIS AND AFTER THE TIME COURSE OF INTRANASALLY ADMINISTERED N-PHENYLACETYL-L-PROLYLGLYCINE ETHYL ESTER (NOOPEPT)

References

1. Cross, A. H., & Naismith, R. T. (2014). Established and novel disease-modifying treatments in multiple sclerosis. Journal of internal medicine, 275(4), 350–363. https://doi.org/10.1111/joim.12203

2. Oh, J., Vidal-Jordana, A., & Montalban, X. (2018). Multiple sclerosis: clinical aspects. Current opinion in neurology, 31(6), 752–759. https://doi.org/10.1097/WCO.0000000000000622

3. Lemus, H. N., Warrington, A. E., & Rodriguez, M. (2018). Multiple Sclerosis: Mechanisms of Disease and Strategies for Myelin and Axonal Repair. Neurologic clinics, 36(1), 1–11. https://doi.org/10.1016/j.ncl.2017.08.002

4. Rosenzweig, R., Nillegoda, N. B., Mayer, M. P., & Bukau, B. (2019). The Hsp70 chaperone network. Nature reviews. Mo- lecular cell biology, 20(11), 665–680. https://doi.org/10.1038/s41580-019-0133-3

5. Faust, O., & Rosenzweig, R. (2020). Structural and Biochemical Properties of Hsp40/Hsp70 Chaperone System. Ad- vances in experimental medicine and biology, 1243, 3–20. https://doi.org/10.1007/978-3-030-40204-4_1

6. BelenichevI.F. Disturbance of HSP70 Chaperone Activity is a pssible mechanism of Mitochodrial Dysfunction / BelenichevI.F.,Bukhtiyarova N.V.,Kolesnik Yu.M., Pavlov S.V., Sokolik E.P // Neurocheм. Journal.-2011.Vol.5,№4.-Р.251-256

7. [Neuroprotection and neuroplasticity] / I.F. Belenichev, i dr. Kiev: Logos, 2015:510. Russian

8. Bojko A. N., Stoljarov I. D., Petrov A. M. [Prospects for new methods for the pathogenetic treatment of multiple sclero- sis]. Nevrol. vestnik im. V. M. Behtereva. 2010; XLII.;1:157-159. Russian

9. [Multiple sclerosis] / E. I. Gusev, T. L. Demina, A. N. Bojko. Moskva;1997:464. Russain

10. Zargarova T. A., Favorova O. O. [Experimental autoimmune encephalomyelitis - a model of multiple sclerosis]. Immu- nologija;1999;2:5 – 8. Russian

11. [Preclinical studies of drugs] / Stefanov A.V. Kiev: Avicenna;2002:568. Russian
Published
2020-11-23
How to Cite
Burlaka, B., Belenichev, I., Samura, I., & Bukhtiyarova, N. (2020). THE CONCENTRATION OF HSP70 IN THE CYTOSOL AND MITOCHONDRIA OF THE BRAIN IN ANIMALS WITH EXPERIMENTAL AUTOIMMUNE ENCEPHALO- MYELITIS AND AFTER THE TIME COURSE OF INTRANASALLY ADMINISTERED N-PHENYLACETYL-L-PROLYLGLYCINE ETHYL ESTER (NOOPEPT). Biological Markers in Fundamental and Clinical Medicine (scientific Journal), 4(2), 34-38. https://doi.org/10.29256/v.04.02.2020.escbm07